Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM6AYDL)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL16709; 54124-67-3; AC1NBNWM; 2-amino-3-methyl-1-(1-pyrrolidinyl)-1-Butanone; SCHEMBL1951493; CTK8J1465; MolPort-004-338-106; ALBB-022686; BDBM50118952; AKOS016347010; AKOS000180650; 1-Pyrrolizino-2-amino-3-methyl-1-butanone; DB-071796; FT-0723537; 2-amino-3-methyl-1-pyrrolidin-1-ylbutan-1-one; F2147-1598; [(1S)-2-methyl-1-(pyrrolidin-1-ylcarbonyl)propyl]amine; 3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-amine hydrochloride; [2-Methyl-1-(pyrrolidin-1-ylcarbonyl)propyl]amine hydrochloride
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||